(Total Views: 124)
Posted On: 04/20/2021 12:18:29 PM
Post# of 25680
$GWHP big news out this week: San Clemente, CA, April 20, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Global WholeHealth Partners (OTC:GWHP) now has the means to identify and test for Dementia using a Micro-Well Reader or Lateral Flow Test to measure the certain brain enzymes during the data collection process used in a positive diagnosis. This was disclosed in an 8K filed March 21, 2021.
"This could simply be described as nothing short of a Medical Breakthrough in Dementia Diagnostic Testing.” -- said Charles Strongo, CEO of Global WholeHealth Partners, Corp (OTC:GWHP).
“We believe this announcement couldn’t come at a better time for us as we are partnering with Nunzia Pharmaceutical and their products for Neurological disorders,” said Mr. Strongo.
"This could simply be described as nothing short of a Medical Breakthrough in Dementia Diagnostic Testing.” -- said Charles Strongo, CEO of Global WholeHealth Partners, Corp (OTC:GWHP).
“We believe this announcement couldn’t come at a better time for us as we are partnering with Nunzia Pharmaceutical and their products for Neurological disorders,” said Mr. Strongo.
(0)
(0)
